The first question in any fundraising or M&A discussion is always, 'What was your last round price?' An inflated number creates psychological friction and can halt negotiations before they begin. Founders should optimize for a valuation that allows for a clear up-round, not just the highest price today.
A massive valuation for a "seed" round can be misleading. Often, insiders have participated in several unannounced, cheaper tranches. The headline number is just the final, most expensive tier, used to create FOMO and set a high watermark for new investors.
Raising too much money at a high valuation puts a "bogey on your back." It forces a "shoot the moon" strategy, which can decrease capital efficiency, make future fundraising harder, and limit potential exit opportunities by making the company too expensive for acquirers.
Instead of stating a single number, introduce price as a range based on what similar customers invest to solve comparable problems. This normalizes the cost, provides a clear budget anchor, and frames the conversation around investment and partnership rather than a transactional price tag.
Valuations don't jump dramatically; they 'sneak up on you.' An investor might balk at a $45M cap when they expected $40M. But the fear of missing a potential unicorn is stronger than the desire for a slightly better price, causing a gradual, batch-over-batch inflation of valuation norms.
Venture rounds are compressing and conflating, with massive "seed" rounds of $30M+ essentially combining a seed and Series A. This sets a dangerous trap: the expectations for your next funding round will be equivalent to those of a traditional Series B company, dramatically raising the bar for growth.
Investors like Reid Hoffman see the fundraising negotiation not as a zero-sum game, but as a crucial test of a founder's character, realism, and suitability as a long-term partner. Unreasonable or unrealistic demands, even in a hot deal, are a negative signal that can kill an investment.
Ben Horowitz advised that pricing is the most critical decision for a company's valuation because it is the primary lever impacting both growth and margins. Founders often treat it glibly, but it deserves deep strategic thought as it underpins the entire business.
A frequent conflict arises between cautious VCs who advise raising excess capital and optimistic founders who underestimate their needs. This misalignment often leads to companies running out of money, a preventable failure mode that veteran VCs have seen repeat for decades, especially when capital is tight.
Reflecting on raising $35M, Ergatta's founder suggests taking less capital might have been wiser. While tempting to raise as much as possible, large funding rounds lock the company into a specific financial trajectory and set of expectations. Raising less money can preserve crucial optionality and flexibility for the business's future.
The founder advises against always pursuing the highest valuation, noting it can lead to immense pressure and difficulties in subsequent rounds if the market normalizes. Prioritizing investor chemistry and a fair, responsible valuation is a more sustainable long-term strategy.